Frequently Asked Questions

When selling or purchasing a business, the structure of the corporate transaction can be important, particularly with respect to contracts, disclosure requirements, and liabilities. In Part One of our series, we introduced high-level distinctions between stock and asset sales, HERE. In today's article, we analyze stock sales in greater detail.

Stock Sale Advantages

The simplest way to purchase a business is to simply buy all of the outstanding stock in the company from the existing shareholder(s).

The business can easily keep running throughout the deal process with little or no interruption. Sometimes the business’s employees and customers will not even be aware that the transaction has taken place.

Nothing needs to be retitled, the contracts all still stay in effect and there is no need for the business’s relationships with employees to change.

Stock Sale Disadvantages

However, there are certain drawbacks to a stock deal. For example, the buyer is buying the entire company and that includes all liabilities associated with that company.

These liabilities can be known or unknown. For example, if a company has debt, then the buyer, as the new owner, would obviously be purchasing the company subject to that debt.

Also, if the company has contractual obligations, then those obligations stay with the company and become the obligations of the new owner.

Furthermore, if the company has some type of ongoing litigation, then the new owner will be responsible for those legal issues as well.

Disclosure of Liabilities

One thing that a buyer should be mindful of is that most businesses could have potential unknown liabilities. For example, after the transaction is completed, someone could come forward and claim that he or she was injured by the company’s product or other actions that occurred before the company was purchased.

Similarly, in the context of a pharmacy sale, the government often commences an investigation years after claims have been paid. If these types of unknown legal issues are not dealt with at the time the company is purchased, the financial implications for the buyer could be devastating.

Dealing with Shareholders

One issue that can make a stock deal impossible is if a minority stockholder does not want to consent to the deal.

Depending on the rights of the minority stockholders provided by the relevant state corporate laws as well as the company’s incorporating documents and any existing shareholder agreements, minority stockholders might be able block a sale of the company’s stock.

Tax Implications

A significant consideration in the sale of any business is tax treatment. In a stock deal, the buyer may lose some tax benefits that are available in an asset sale.

Depending on the facts of the deal, these tax benefits can be substantial. In Part Three of our series, we will discuss the tax advantages of doing an asset sale.

Conclusion

It is often also a good idea to seek the advice of competent legal counsel early in the negotiation process to determine which type of deal structure would benefit you the most. Please do not hesitate to contact us with any questions.

MORE ARTICLES BY CATEGORY

Get a Free Case REVIEW

100% Confidential & Secure. Your details are safe with us.

We'll speak soon!

In the meantime, why not find out more about us or visit our blog.

Alternatively, give us a call at (800) 345 - 4125

Oops! Something went wrong while submitting the form.

Resolving Prescription “Red Flags” Is No Longer Optional: Federal Scrutiny Tightens on Controlled-Substance Dispensing

Pharmacists must resolve “red flags” under the Controlled Substances Act’s corresponding-responsibility requirements before dispensing controlled substances. Overlooking warning signs, such as cash-paid, high-dose opioid prescriptions—can now trigger False Claims Act liability and massive penalties, as demonstrated by Walgreens’ $350 million settlement in April 2025.

Read More >>

9th Circuit’s Landmark EKRA Ruling—What Providers Should Know

On July 11, 2025, the 9th Circuit upheld a laboratory operator’s convictions for violating EKRA by paying marketing agents to mislead providers into providing patient referrals for medically unnecessary blood tests. In this article, we analyze the 9th Circuit’s ruling and what it means for the future of EKRA enforcement.

Read More >>

Collateral Consequences Mount Quickly After Adverse DEA Inspection

Adverse findings during a DEA inspection can trigger a chain reaction of serious consequences for pharmacies, including increasing fines, suspension or revocation of DEA registrations and pharmacy licenses, costly False Claims Act (FCA) lawsuits, and potential criminal liability.

Read More >>

Heath Law Alliance Secures Reversal of a Medicaid Payment Suspension

Health Law Alliance successfully secured a full reversal of a Medi-Cal payment suspension for a California pharmacy, overturning speculative allegations made by the Department of Health Care Services. This case highlights the firm’s ability to protect healthcare providers against unjust enforcement actions and the critical value of experienced legal counsel in Medicaid and insurance disputes.

Read More >>